Early eczema drug trial halted after limited testing
Disease control
Terminated
This early-stage study aimed to test the safety and effectiveness of an experimental drug called IMG-007 for adults with moderate-to-severe eczema (atopic dermatitis). Participants received the drug or a placebo through IV infusions over several weeks. The trial was terminated ea…
Phase: PHASE1, PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC